Background The degree of protective immunity conferred by infection with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently unknown. As such, the possibility …

The parameters involved in human cytomegalovirus (HCMV) latent infection in CD14 (+) and
CD34 (+) cells remain poorly identified. Using next generation sequencing we deduced the …

Kaposi's sarcoma-associated herpesvirus (KSHV) is the cause of Kaposi's sarcoma and body
cavity lymphomas. KSHV lytic infection produces PAN RNA, a highly abundant noncoding …

Kaposi's sarcoma-associated herpesvirus (KSHV) is the cause of Kaposi's sarcoma and body
cavity lymphoma. In cell culture, KSHV results in a latent infection, and lytic reactivation is …

During lytic infection, Kaposi's sarcoma-associated herpesvirus (KSHV) expresses a
polyadenylated nuclear RNA (PAN RNA). This noncoding RNA (ncRNA) is localized to the nucleus …

Kaposi’s sarcoma-associated herpesvirus (KSHV) is an oncogenic γ-herpesivrus, the
causative agent of Kaposi’s sarcoma and body cavity lymphomas. During infection KSHV …

Human cytomegalovirus (HCMV) can establish latent infection in hematopoietic progenitor
cells (HPCs) or CD14 (+) monocytes. While circularized viral genomes are observed during …

Human cytomegalovirus (HCMV) is a member of the Herpesviridae family that infects individuals
throughout the world. Following an initial lytic stage, HCMV can persist in the individual …

Patients with signs of COVID-19 were tested through diagnostic RT-PCR for SARS-CoV-2
using RNA extracted from the nasopharyngeal/nasal swabs. To determine the variants of …

Human cytomegalovirus transient lytic DNA replication relies on the cis-acting element oriLyt,
six viral-encoded core proteins, the proposed DNA replication initiator protein UL84, IE2, …